Vaccine hesitancy, anti-Vax campaigners and misinformation hound the administration of vaccines. Our study, conducted at Malwa region of the Punjab, India, was systematically carried out to look for adverse neurological effects after COVID-19 vaccination, given to 1000 people (>18 years and <60 years) who had received either single or multiple doses. No major neurological complications were found; the only side-effect was a transitory headache in 15% of the participants.
PolackFPThomasSJKitchinN, et al.Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med2020; 383: 2603–2615.
2.
BadenLREl SahlyHMEssinkB, et al.Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med2021; 384: 403–416.
3.
VoyseyMClemensSAMadhiSA, et al.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet2021; 397: 99–111.
4.
SadoffJGrayGVandeboschA, et al.Safety and efficacy of single-dose Ad26. COV2. S vaccine against COVID-19. N Engl J Med2021; 384: 2187–2201.
5.
HeathPTGalizaEPBaxterDN, et al.Safety and efficacy of NVX-CoV2373 COVID-19 vaccine. N Engl J Med2021; 385: 1172–1183.
6.
GöbelCHHeinzeAKarstedtS, et al.Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study. Pain Ther2021; 10: 1309–1330.
7.
PottegardALundLCKarlstadO, et al.Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford- AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. Br Med J2021; 373: 1114.
8.
Hippisley-CoxJPatoneMMeiXW, et al.Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: self- controlled case series study. Br Med J2021; 374: 1931.
9.
PatelSUKhurramRLakhaniA,et al.Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep CP2021; 14: e242956.
10.
MalhotraHSGuptaPPrabhuV, et al.COVID-19 vaccination- associated myelitis. QJM: Int J Med2021; 114: 591–593.
11.
ColellaGOrlandiMCirilloN. Bell’s palsy following COVID-19 vaccination. J Neurol2021; 268: 3589–3591.
12.
COVID E. Vaccine janssen: guillain-barré syndrome listed as a very rare side effect. Europ Med Agency2021; 19: 22.
13.
MatarnehASAl-battahAHFarooquiK, et al.COVID-19 vaccine causing guillain-barre syndrome, a rare potential side effect. Clin Case Rep2021; 9: e04756.
14.
RazokAShamsAAlmeerA,et al.Post-COVID-19 vaccine guillain-barré syndrome; first reported case from Qatar. Ann Med Surg2021; 67: 102540.
15.
WaheedSBayasAHindiF, et al.Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus2021; 13: e13426.
16.
HughesDLBrunnJAJacobsJ, et al.Guillain-barre syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl2022; 28: 134–137.
17.
Darin-MattssonAForsSKåreholtI. Different indicators of socioeconomic status and their relative importance as determinants of health in old age. Int J Equity Health2017; 16: 173.
18.
ChenLLiangHLiuL, et al.The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose. Hum Vaccin Immunother2023; 19: 2176643.
19.
KhatamiSSRevheimMEHøilund-CarlsenPF, et al.Central nervous system manifestations following vaccination against COVID-19. Brain Behav Immun- Health2024; 38: 100788.
20.
SekiguchiKWatanabeNMiyazakiN, et al.Incidence of headache after COVID-19 vaccination in patients with history of headache: a cross- sectional study. Cephalalgia2022; 42: 266–272.
21.
GobelCHHeinzeAKarstedtS, et al.Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study. Pain Ther2021; 10: 1309–1330.
22.
BolayHOzgeAUluduzD,et al.Are migraine patients at increased risk for symptomatic coronavirus disease due to shared comorbidities?Headache: J Head Face Pain2020; 60: 2508–2521.
23.
Trigo-LopezJGarciA-AzorinDSierra-MenciaA, et al.Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE- control, study on 104 patients. J Headache Pain2021; 22: 51.
24.
JameieMToghaM, Azizmohammad et al.Characteristics of headaches attributed to SARS-CoV 2 vaccination and factors associated with its frequency and prolongation: a cross-sectional cohort study. Front Neurol. 2023;14:1214501
